Connection

Michael Lilly to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Drug Therapy, Combination.
Michael Lilly
Connection Strength
0.016
Drug Therapy, Combination
  1. Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway. Leukemia. 2008 Jan; 22(1):138-46.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.